ProPhase Labs (PRPH) Misses Q3 EPS by 5c, Misses on Revenue

ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $880 thousand versus the consensus estimate of $5.69 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'
• Active options: AMD SNDK IREN GOOGL PLTR AVGO SOFI NKE MSTR NBIS ORCL